Blood Disorders in Patients Undergoing Transcatheter Aortic Valve Replacement: A Review.

[1]  F. Maes,et al.  Meta-Analysis Comparing Single Versus Dual Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation. , 2018, The American journal of cardiology.

[2]  M. Leon,et al.  Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis. , 2017, International journal of cardiology.

[3]  C. Hengstenberg,et al.  Prognostic impact of anemia and iron-deficiency anemia in a contemporary cohort of patients undergoing transcatheter aortic valve implantation. , 2017, International journal of cardiology.

[4]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.

[5]  K. Kamiński,et al.  Thrombocytopenia associated with TAVI-The summary of possible causes. , 2017, Advances in medical sciences.

[6]  Tania Rodríguez-Gabella,et al.  Latest-Generation Transcatheter Aortic Valve Replacement Devices and Procedures. , 2017, The Canadian journal of cardiology.

[7]  J. Marsal,et al.  Predictors and Association With Clinical Outcomes of the Changes in Exercise Capacity After Transcatheter Aortic Valve Replacement , 2017, Circulation.

[8]  K. Kamiński,et al.  The causes of thrombocytopenia after transcatheter aortic valve implantation. , 2017, Thrombosis research.

[9]  C. Grines,et al.  Incidence and Outcomes of Heparin-Induced Thrombocytopenia in Patients Undergoing Transcatheter Aortic Valve Replacement. , 2017, The American journal of cardiology.

[10]  D. Houston The riddle of thrombocytopenia following transcatheter aortic valve implantation. , 2017, Thrombosis research.

[11]  A. Regueiro,et al.  Combined erythropoietin and iron therapy for anaemic patients undergoing transcatheter aortic valve implantation: the EPICURE randomised clinical trial. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[12]  P. Serruys,et al.  Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation , 2017, Clinical Research in Cardiology.

[13]  Jiayang Wang,et al.  Risk Factors for Post-TAVI Bleeding According to the VARC-2 Bleeding Definition and Effect of the Bleeding on Short-Term Mortality: A Meta-analysis. , 2017, The Canadian journal of cardiology.

[14]  M. Mack,et al.  Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry , 2017, JAMA cardiology.

[15]  J. Oldenburg,et al.  Transcatheter aortic valve implantation leads to a restoration of von Willebrand factor (VWF) abnormalities in patients with severe aortic stenosis - Incidence and relevance of clinical and subclinical VWF dysfunction in patients undergoing transfemoral TAVI. , 2017, Thrombosis research.

[16]  S. Blankenberg,et al.  Baseline anemia and its impact on midterm outcome after transcatheter aortic valve implantation , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[17]  J. Oldenburg,et al.  TAVI induces an elevation of hemostasis-related biomarkers, which is not causative for post-TAVI thrombocytopenia. , 2016, International journal of cardiology.

[18]  Y. Arbel,et al.  Impact of Hemoglobin Drop, Bleeding Events, and Red Blood Cell Transfusions on Long-term Mortality in Patients Undergoing Transaortic Valve Implantation. , 2016, The Canadian journal of cardiology.

[19]  A. MacLullich,et al.  The relationship between preoperative frailty and outcomes following transcatheter aortic valve implantation: a systematic review and meta-analysis , 2016, European heart journal. Quality of care & clinical outcomes.

[20]  P. Austin,et al.  Preprocedure Anemia Management Decreases Transfusion Rates in Patients Undergoing Transcatheter Aortic Valve Implantation. , 2016, The Canadian journal of cardiology.

[21]  T. Rassaf,et al.  Red cell distribution width in anemic patients undergoing transcatheter aortic valve implantation. , 2016, World journal of cardiology.

[22]  R. Charnigo,et al.  Thromboinflammatory response and predictors of outcomes in patients undergoing transcatheter aortic valve replacement , 2016, Journal of Thrombosis and Thrombolysis.

[23]  C. Macaya,et al.  Incidence, Causes, and Predictors of Early (≤30 Days) and Late Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement. , 2015, JACC. Cardiovascular interventions.

[24]  O. Morel,et al.  Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor. , 2015, The Canadian journal of cardiology.

[25]  P. Leprince,et al.  Impact of pre‐ and post‐procedural anemia on the incidence of acute kidney injury and 1‐year mortality in patients undergoing transcatheter aortic valve implantation (from the French Aortic National CoreValve and Edwards 2 [FRANCE 2] Registry) , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[26]  K. Kuck,et al.  Treatment of acquired von Willebrand syndrome in aortic stenosis with transcatheter aortic valve replacement. , 2015, JACC. Cardiovascular interventions.

[27]  John D. Carroll,et al.  Clinical outcomes at 1 year following transcatheter aortic valve replacement. , 2015, JAMA.

[28]  R. Schnabel,et al.  Blood transfusion is associated with impaired outcome after transcatheter aortic valve implantation , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[29]  J. Rodés‐Cabau,et al.  Effect on outcomes and exercise performance of anemia in patients with aortic stenosis who underwent transcatheter aortic valve replacement. , 2015, The American journal of cardiology.

[30]  Jeroen J. Bax,et al.  Value of the "TAVI2-SCORe" versus surgical risk scores for prediction of one year mortality in 511 patients who underwent transcatheter aortic valve implantation. , 2015, The American journal of cardiology.

[31]  L. Biasco,et al.  Recovery from Anemia in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation – Prevalence, Predictors and Clinical Outcome , 2014, PloS one.

[32]  A. Kirtane,et al.  Acquired thrombocytopenia after transcatheter aortic valve replacement: clinical correlates and association with outcomes. , 2014, European heart journal.

[33]  U. Benedetto,et al.  European real world trans-catheter aortic valve implantation: systematic review and meta-analysis of European national registries , 2015, Journal of Cardiothoracic Surgery.

[34]  Thoralf M Sundt,et al.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[35]  D. Wood,et al.  Blood loss and transfusion rates associated with transcatheter aortic valve replacement: Recommendations for patients who refuse blood transfusion , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[36]  Daniel E Forman,et al.  Frailty assessment in the cardiovascular care of older adults. , 2014, Journal of the American College of Cardiology.

[37]  F. Welt,et al.  Incidence and implications of idiopathic thrombocytopenia following transcatheter aortic valve replacement with the Edwards Sapien© valves: A single center experience , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[38]  S. Schrier,et al.  Evaluation and management of anemia in the elderly , 2014, American journal of hematology.

[39]  J. Mega,et al.  Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. , 2013, Journal of the American College of Cardiology.

[40]  J. Maessen,et al.  Prevalence, Factors Associated With, and Prognostic Effects of Preoperative Anemia on Short- and Long-Term Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation , 2013, Circulation. Cardiovascular interventions.

[41]  J. Dubois-Randé,et al.  Effect of transcatheter (via femoral artery) aortic valve implantation on the platelet count and its consequences. , 2013, The American journal of cardiology.

[42]  O. Alfieri,et al.  Heyde's syndrome incidence and outcome in patients undergoing transcatheter aortic valve implantation. , 2013, Journal of the American College of Cardiology.

[43]  J. Loscalzo From clinical observation to mechanism--Heyde's syndrome. , 2012, The New England journal of medicine.

[44]  J. Maessen,et al.  Blood Transfusion and the Risk of Acute Kidney Injury After Transcatheter Aortic Valve Implantation , 2012, Circulation. Cardiovascular interventions.

[45]  P. Serruys,et al.  Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[46]  D. Wood,et al.  Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[47]  Howard K. Song,et al.  2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. , 2011, The Annals of thoracic surgery.

[48]  J. Kelder,et al.  Combined coronary artery bypass grafting and aortic valve replacement with minimal extracorporeal closed circuit circulation versus standard cardiopulmonary bypass. , 2010, Interactive cardiovascular and thoracic surgery.

[49]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.

[50]  G. Lemesle,et al.  The clinical significance of hematocrit values before and after percutaneous coronary intervention. , 2009, American heart journal.

[51]  A. D. de Wolf,et al.  Preoperative Hemoglobin Level as a Predictor of Survival After Coronary Artery Bypass Grafting: A Comparison With the Matched General Population , 2009, Circulation.

[52]  D. Wijeysundera,et al.  Risk Associated With Preoperative Anemia in Cardiac Surgery: A Multicenter Cohort Study , 2008, Circulation.

[53]  R. Stocker,et al.  Time course of hemoglobin concentrations in the intensive care unit in nonbleeding patients with acute coronary syndrome. , 2007, The American journal of cardiology.

[54]  I. C. Tudor,et al.  Impact of Preoperative Anemia on Outcome in Patients Undergoing Coronary Artery Bypass Graft Surgery , 2007, Circulation.

[55]  S. Brister,et al.  Does the Use of Erythropoietin Reduce the Risk of Exposure to Allogeneic Blood Transfusion in Cardiac Surgery? A Systematic Review and Meta‐Analysis , 2006, Journal of cardiac surgery.

[56]  Luigi Ferrucci,et al.  Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. , 2004, Blood.

[57]  Tania Rodríguez-Gabella,et al.  Future of transcatheter aortic valve implantation — evolving clinical indications , 2018, Nature Reviews Cardiology.

[58]  H. Jilaihawi,et al.  Major thrombocytopenia after balloon‐expandable transcatheter aortic valve replacement: Prognostic implications and comparison to surgical aortic valve replacement , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[59]  G. Hirsch,et al.  VALVULAR AND STRUCTURAL HEART DISEASES Original Studies Predictors and Clinical Impact of Pre-existing and Acquired Thrombocytopenia Following Transcatheter Aortic Valve Replacement , 2014 .

[60]  Josep Rodés-Cabau,et al.  Transcatheter aortic valve implantation: current and future approaches , 2012, Nature Reviews Cardiology.